Song Wei, Zhang Tianyang, Li Wei, Mu Rui, Zhang Lingyi, Li Yan, Jin Baofeng, Wang Na, Li Ailing, Cui Jiuwei
a Cancer Center, the First Hospital of Jilin University , Changchun , China.
b Institute of Basic Medical Sciences , National Center of Biomedical Analysis , Beijing , China.
Cancer Invest. 2015;33(9):469-75. doi: 10.3109/07357907.2015.1069831. Epub 2015 Aug 25.
This study aimed to investigate the expression of Friend leukemia virus integration 1 (Fli-1) and its correlation with the prognosis of endometrial cancer (EC). Thirty-two EC tissue samples were evaluated for Fli-1 expression using immunohistochemistry. Fli-1 showed significantly high expression in EC cells, followed by hyperplasia cells, and was negative in adjacent normal tissues. The high expression of Fli-1 was significantly associated with a high differentiation grade, mutated P53 expression, and histological subtype (p < .05). Downregulation of Fli-1 in AN3CN cells using RNA interference inhibited cell clone formation and proliferation but did not affect apoptosis and migration of the cells. This study provides the first evidence that Fli-1 expression gradually increases in parallel with disease progression, and its overexpression might predict poor prognosis in EC.
本研究旨在探讨Friend白血病病毒整合1(Fli-1)的表达及其与子宫内膜癌(EC)预后的相关性。采用免疫组织化学方法对32例EC组织样本进行Fli-1表达评估。Fli-1在EC细胞中呈显著高表达,其次是增生细胞,在相邻正常组织中呈阴性。Fli-1的高表达与高分化程度、P53突变表达及组织学亚型显著相关(p < 0.05)。使用RNA干扰下调AN3CN细胞中Fli-1的表达可抑制细胞克隆形成和增殖,但不影响细胞凋亡和迁移。本研究首次提供证据表明,Fli-1表达随疾病进展逐渐升高,其过表达可能预示EC预后不良。